Breast cancer prevention: Patient decision making and risk communication in the high risk setting

Breast Journal

Volumn 16, Issue 1, 2010, Pages 38-47

  Ozanne, Elissa M ^a   Wittenberg, Eve ^a   Garber, Judy E ^b   Weeks, Jane C ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRANDEIS UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Decision making; Genetic mutations; Genetic testing; Risk communication; Risk perception

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN EXPERIMENT; INTERPERSONAL COMMUNICATION; PATIENT COUNSELING; PATIENT DECISION MAKING; PREVENTIVE MEDICINE; RISK ASSESSMENT;

ADULT; AGE FACTORS; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMMUNICATION; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MIDDLE AGED; PATIENT PREFERENCE; PHYSICIAN-PATIENT RELATIONS; PRIMARY PREVENTION; QUESTIONNAIRES; REGISTRIES; RISK ASSESSMENT; RISK-TAKING; YOUNG ADULT;

EID: 77249150997     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00857.x     Document Type: Article

References (34)

1. American Cancer Society. Cancer Facts and Figures. Atlanta: American Cancer Society, 2008.
2. Meijers-Heijboer H, Van Geel B, Van Putten W, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001;345: 159-64.
3. Rebbeck TR. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999;91:1475-9.
4. Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001;93:1633-7.
5. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 2004; 22:1055-62.
6. Hartmann LC, Degnim A, Schaid DJ. Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions. J Clin Oncol 2004;22:981-3.
7. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study [see comments]. J Natl Cancer Inst 1998;90:1371-88.
8. Claus EB. Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians. Fam Cancer 2001;1:197-206.
9. Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL. Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 2003;21:593-601.
10. Martin W, Lobchuk M. Breast cancer risk perception and surveillance: an integrative review. Online J Knowl Synth Nurs 2003;10:2.
11. Lipkus IM, Biradavolu M, Fenn K, Keller P, Rimer BK. Informing women about their breast cancer risks: truth and consequences. Health Commun 2001;13:205-26.
12. Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst 2002;94:1564-9.
13. Finney Rutten LJ, Iannotti RJ. Health beliefs, salience of breast cancer family history, and involvement with breast cancer issues: adherence to annual mammography screening recommendations. Cancer Detect Prev 2003;27:353-9.
14. Finney LJ, Iannotti RJ. The impact of family history of breast cancer on women's health beliefs, salience of breast cancer family history, and degree of involvement in breast cancer issues. Women Health 2001;33:15-28.
15. Silverman E, Woloshin S, Schwartz LM, Byram SJ, Welch HG, Fischhoff B. Women's views on breast cancer risk and screening mammography: a qualitative interview study. Med Decis Making 2001;21:231-40.
16. Green MJ, Peterson SK, Baker MW, et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA 2004;292:442-52.
17. Stacey D, O'Connor AM, DeGrasse C, Verma S. Development and evaluation of a breast cancer prevention decision aid for higher-risk women. Health Expect 2003;6:3-18.
18. Alexander NE, Ross J, Sumner W, Nease RF Jr, Littenberg B. The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 1996;11:92-7.
19. Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-92.
20. Gurmankin AD, Domchek S, Stopfer J, Fels C, Armstrong K. Patients' resistance to risk information in genetic counseling for BRCA1/2. Arch Intern Med 2005;165:523-9.
21. Carlson RW, McCormick B. Update: NCCN breast cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 2005;3(Suppl 1):S7-11.
22. Eccles DM, Evans DG, Mackay J. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). J Med Genet 2000;37:203-9.
23. Braddock CH 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA 1999;282:2313-20.
24. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81: 1879-86.
25. Claus E, Risch N, Thompson W. Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction. Cancer 1994;73:643-51.
26. Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 2003; 178:77-81.
27. Lindberg NM, Wellisch D. Anxiety and compliance among women at high risk for breast cancer. Ann Behav Med 2001; 23:298-303.
28. Lobb EA, Butow PN, Barratt A, et al. Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes. Br J Cancer 2004;90:321-7.
29. Keating NL, Weeks JC, Borbas C, Guadagnoli E. Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed? Breast Cancer Res Treat 2003;79:225-31.
30. Lee SJ, Back AL, Block SD, Stewart SK. Enhancing physician-patient communication. Hematology Am Soc Hematol Educ Program 2002;464-83.
31. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decisionmaking model. Soc Sci Med 1999;49:651-61.
32. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997;44:681-92.
33. Coulter A. Partnerships with patients: the pros and cons of shared clinical decision-making. J Health Serv Res Policy 1997; 2:112-21.
34. Moumjid N, Gafni A, Bremond A, Carrere MO. Shared decision making in the medical encounter: are we all talking about the same thing? Med Decis Making 2007;27:539-46.